Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 20 Lung Neoplasms 6 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Breast Neoplasms 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms 2 Lymphoma, Non-Hodgkin 2 Head and Neck Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Urinary Bladder Diseases 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Thrombocytosis 1 Testicular Neoplasms 1

Interventions

pembrolizumab 8 avelumab 6 fludarabine 3 Radiotherapy 3 Radiation 3 Cyclophosphamide 3 cemiplimab 2 atezolizumab 2 aldesleukin 2 Interleukin-2 2 Interferon-beta 2 ALT-803 2 talimogene laherparepvec 1 poly ICLC 1 pentetreotide 1 interferon gamma-1b 1 epacadostat 1 efineptakin alfa 1 durvalumab 1 cabozantinib 1 bempegaldesleukin 1 TTI-621 1 Paclitaxel 1 Nivolumab 1 Interferon-gamma 1 Influenza Vaccines 1 Immunotherapy 1 High-Intensity Focused Ultrasound Ablation 1 Carboxylesterase 1 B7-H1 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Merkel Cell × durvalumab × Clear all

NCT06939036 2026-02-05

SANTANA-225

Ariceum Therapeutics GmbH

Phase 1/2 Terminated

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡